Epidemiology, Treatment, and Epidemic Prevention and Control of the Coronavirus Disease 2019: a Review
-
LUAN Rong-sheng,
-
WANG Xin,
-
SUN Xin,
-
CHEN Xing-shu,
-
ZHOU tao,
-
LIU Quan-hui,
-
LÜ Xin,
-
WU Xian-ping,
-
GU Dong-qing,
-
TANG Ming-shuang,
-
CUI Hui-jie,
-
SHAN Xue-feng,
-
OUYANG Jing,
-
ZHANG Ben,
-
ZHANG Wei,
-
Sichuan University COVID-19 Emergency Research Group
-
Abstract
This review summarizes the ongoing researches regarding etiology, epidemiology, transmission dynamics, treatment, and prevention and control strategies of the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with comparison to severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and pandemic H1N1 virus. SARS-CoV-2 may be originated from bats, and the patients and asymptomatic carriers are the source of epidemic infection. The virus can be transmitted human-to-human through droplets and close contact, and people at all ages are susceptible to this virus. The main clinical symptoms of the patients are fever and cough, accompanied with leukocytopenia and lymphocytopenia. Effective drugs have been not yet available thus far. In terms of the prevention and control strategies, vaccine development as the primary prevention should be accelerated. Regarding the secondary prevention, ongoing efforts of the infected patients and close contacts quarantine, mask wearing promotion, regular disinfection in public places should be continued. Meanwhile, rapid detection kit for serological monitoring of the virus in general population is expected so as to achieve early detection, early diagnosis, early isolation and early treatment. In addition, public health education on this disease and prevention should be enhanced so as to mitigate panic and mobilize the public to jointly combat the epidemic.
-
-